Poolbeg Pharma Share Discussion Threads

[troutisout] 28/6/2023 17:40

Chunky buy just gone through from just after Midday...

[rafboy] 28/6/2023 16:19

Noted Shrewdmole.

[adorling] 28/6/2023 15:05

………;something big about to land???

[shrewdmole] 28/6/2023 14:48

Raf

Just looks like a free market tightly held no overhang so mm moving with buys and sells.

Makes a change!!

S

[rafboy] 28/6/2023 14:43

Very strong move, news soon?

[shrewdmole] 28/6/2023 14:33

Very tight supply …

[mark10101] 28/6/2023 14:15

Tight supply again where very little buying ticks things up, if we get news hopefully we can return to the double digits we’re at a few years ago.

[alphabravo321] 28/6/2023 14:02

It is alive...

[rafboy] 28/6/2023 13:48

Bit of interest and up we go.

[extrader] 22/6/2023 11:23

Thanks, 1gw.

[1gw] 22/6/2023 09:41

I guess there's nothing to stop POLB trying to monetise their interest before they get to the Phase 1 trial. e.g. they might feel that if they can get proof of concept on the encapsulation then they have already got something of interest to bigger companies.

Or it could be that they're prepared to take on longer-wavelength projects where they can secure non-dilutive funding (in this case a grant) for them.

[extrader] 22/6/2023 09:34

This is quite a lengthy road-map...

"..the EncOVac Consortium parties are now entering the next phase to commence the validation of the encapsulation process. The validation is expected to complete in H2 2023.

Taking place over three years, the EncOVac Consortium is funded to develop a Phase I clinical trial ready oral vaccine candidate. The agreed research plan includes several stages of work and once the encapsulation process, developed by AnaBio Technologies, has been successfully validated, the consortium will proceed to encapsulate vaccine antigen candidates ..... This oral vaccine candidate will then complete all required non-clinical testing in preparation for a Phase I clinical trial..."

POLB was premised on 'fast-tracking to early monetisation/rejection', AIUI.

This doesn't seem to be achieving that, AFAICS.

What am I missing?

[1gw] 22/6/2023 09:13

Underwhelming RNS this morning, then.

[chica1] 20/6/2023 15:50

Ex...Cytoreason AI data results are supposedly due before the end of the month.

[extrader] 20/6/2023 15:46

Hi elrico

What data...and what date, pls?

Asleep at the back of the class...;-<<br />
TIA

[elrico] 20/6/2023 13:47

MM will mug a few PIs ahead of the Q2 data. Basic stuff, but some will fall for it.

[ih_486726] 20/6/2023 12:28

Wrong board. Sorry.

[chica1] 20/6/2023 12:23

Is Ian O’Connell full-time CFO at Poolbeg or is he working on other projects within the Raglan Capital group?

[bobsworth] 16/6/2023 14:51

Love that word "Blockbuster". So picked up another 2 x 50,000 today ?

[klosters65] 14/6/2023 08:41

Bid 8.70. /. Ask 9.20. Market makers not exactly making a trading market.

[jansky61] 14/6/2023 08:27

I just had to pay 9.08 for 20k more shares

[adorling] 13/6/2023 06:42

Just re-posting as a reminder:

After a lack of any meaningful development news flow in the past few months we are due news by endQ2 on the AI RSV Therapeutics (One Three Biotech) lab based drug targets and the AI Influenza (CytoReason)drug targets plus of course possible updates on out-licensing discussions on POLB001 which will be the big news.

So next 2 weeks should see price move back towards 10p and beyond on this news flow.

[master investor] 12/6/2023 12:26

Hvo divi money being invested here

[lauders] 12/6/2023 10:09

Will we reach 9p today? Would be nice. Hope there is a good reason for the recent strength and long may it continue.

[baldrick1] 12/6/2023 09:21

7percent profit takers on the move now